← back to search

Pavithra Viswanath

City College of San Francisco · US
Area of research
Genetics · Cancer Research
Research interest
Research interests include Glioma Diagnosis and Treatment, Cancer, Hypoxia, and Metabolism, Mitochondrial Function and Pathology, and Advanced NMR Techniques and Applications.
h-index
24
citations
1,454
works
143
NIH funding
primary concept
email

Recent publications

TMET-51. EGFR metabolically suppresses differentiation in H3K27M-mutant diffuse midline glioma
Neuro-Oncology 2025cited by 0position: middledoi
IMG-31. DEUTERIUM METABOLIC IMAGING OF RESPONSE TO PRECISION THERAPY IN BRAF-V600E MUTANT GLIOMAS
Neuro-Oncology 2024cited by 0position: lastdoi
BIOM-23. DEUTERIUM METABOLIC IMAGING OF RESPONSE TO PRECISION THERAPY IN BRAF-V600E MUTANT GLIOMAS
Neuro-Oncology 2024cited by 0position: lastdoi
Deuterium Metabolic Imaging Reports on TERT Expression and Early Response to Therapy in Cancer
Clinical Cancer Research 2022cited by 42position: lastdoi
Metabolic imaging detects elevated glucose flux through the pentose phosphate pathway associated with TERT expression in low-grade gliomas
Neuro-Oncology 2021cited by 47position: firstdoi
Ferronostics: Measuring Tumoral Ferrous Iron with PET to Predict Sensitivity to Iron-Targeted Cancer Therapies
Journal of Nuclear Medicine 2020cited by 55position: middledoi
In vivo detection of γ-glutamyl-transferase up-regulation in glioma using hyperpolarized γ-glutamyl-[1-13C]glycine
Scientific Reports 2020cited by 27position: middledoi
PI3K/mTOR inhibition of IDH1 mutant glioma leads to reduced 2HG production that is associated with increased survival
Scientific Reports 2019cited by 64position: middledoi
Clonal expansion and epigenetic reprogramming following deletion or amplification of mutant <i>IDH1</i>
Proceedings of the National Academy of Sciences 2017cited by 140position: middledoi
Rapid Conversion of Mutant IDH1 from Driver to Passenger in a Model of Human Gliomagenesis
Molecular Cancer Research 2016cited by 111position: middledoi
Mutant IDH1 Expression Drives <i>TERT</i> Promoter Reactivation as Part of the Cellular Transformation Process
Cancer Research 2016cited by 61position: middledoi
<i>IDH1</i> Mutation Induces Reprogramming of Pyruvate Metabolism
Cancer Research 2015cited by 122position: middledoi
Metabolic Reprogramming in Mutant IDH1 Glioma Cells
PLoS ONE 2015cited by 80position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Sabrina M. Ronen · University of California, San Francisco8 papers (2015–2022)Russell O. Pieper · University of California, San Francisco6 papers (2015–2021)Georgios Batsios · University of California, San Francisco6 papers (2019–2024)Anne Marie Gillespie · University of California, San Francisco6 papers (2019–2024)J Costello · City College of San Francisco3 papers (2016–2022)Joanna J. Phillips · UCSF Helen Diller Family Comprehensive Cancer Center3 papers (2015–2016)Claudia Petritsch · Stratford University2 papers (2024–2024)Sabine Mueller · Philadelphia University2 papers (2024–2024)Myriam M. Chaumeil · University of California, San Francisco2 papers (2015–2015)Suresh Udutha · University of California System2 papers (2024–2024)Pia Eriksson · University of California System2 papers (2015–2015)Tor-Christian Aase Johannessen · University of California, San Francisco2 papers (2016–2016)Joydeep Mukherjee · Bangur Institute of Neurosciences2 papers (2016–2016)H. Artee Luchman · University of Calgary2 papers (2015–2021)Shigeo Ohba · Fujita Health University Hospital2 papers (2016–2016)José Luis Izquierdo-García · Universidad Complutense de Madrid2 papers (2015–2015)Peder E. Z. Larson · University of California, San Francisco2 papers (2020–2021)Chloé Najac · Leiden University Medical Center2 papers (2019–2020)Elavarasan Subramani · The University of Texas MD Anderson Cancer Center2 papers (2019–2020) · 1 papers (2020–2020)